Presentation of a cytosolic antigen by major histocompatibility complex class II molecules requires a long-lived form of the antigen

被引:49
|
作者
Gueguen, M [1 ]
Long, EO [1 ]
机构
[1] NIAID,IMMUNOGENET LAB,NIH,ROCKVILLE,MD 20852
关键词
antigen processing; HLA-DR; N-end rule; protein degradation; ubiquitin;
D O I
10.1073/pnas.93.25.14692
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Class I and class II molecules of the major histocompatibility complex present peptides to T cells, Class I molecules bind peptides that hare been generated in the cytosol by proteasomes and delivered into the endoplasmic reticulum by the transporter associated with antigen presentation, In contrast, class II molecules are very efficient in the presentation of antigens that have been internalized and processed in endosomal lysosomal compartments, In addition, class II molecules can present some cytosolic antigens by a TAP-independent pathway. To test whether this endogenous class II presentation pathway was linked to proteasome-mediated degradation of antigen in the cytosol, the N-end rule was utilized to produce two forms of the influenza virus matrix protein with different in vivo half-lives (10 min vs. 5 h) when expressed in human B cells, Whereas class I molecules presented both the short- and the long-lived matrix proteins, class II molecules presented exclusively the long-lived form of antigen, Thus, rapid degradation of matrix protein in the cytosol precluded its presentation by class II molecules, These data suggest that the turnover of long-lived cytosolic proteins, some of which is mediated by delivery into endosomal/lysosomal compartments, provides a mechanism for immune surveillance by CD4(+) T cells.
引用
收藏
页码:14692 / 14697
页数:6
相关论文
共 50 条
  • [41] Enhanced germinal center reaction by targeting vaccine antigen to major histocompatibility complex class II molecules
    Tor Kristian Andersen
    Peter C. Huszthy
    Ramakrishna P. Gopalakrishnan
    Johanne T. Jacobsen
    Marte Fauskanger
    Anders A. Tveita
    Gunnveig Grødeland
    Bjarne Bogen
    npj Vaccines, 4
  • [42] Peptidomimetic compounds that inhibit antigen presentation by autoimmune disease-associated class II major histocompatibility molecules
    Fiorenza Falcioni
    Kouichi Ito
    Damir Vidovic
    Charles Belunis
    Robert Campbell
    Steven J. Berthel
    David R. Bolin
    Paul B. Gillespie
    Nicholas Huby
    Gary L. Olson
    Ramakanth Sarabu
    Jeanmarie Guenot
    Vincent Madison
    Jürgen Hammer
    Francesco Sinigaglia
    Michael Steinmetz
    Zoltan A. Nagy
    Nature Biotechnology, 1999, 17 : 562 - 567
  • [43] Peptidomimetic compounds that inhibit antigen presentation by autoimmune disease-associated class II major histocompatibility molecules
    Falcioni, F
    Ito, K
    Vidovic, D
    Belunis, C
    Campbell, R
    Berthel, SJ
    Bolin, DR
    Gillespie, PB
    Huby, N
    Olson, GL
    Sarabu, R
    Guenot, J
    Madison, V
    Hammer, J
    Sinigaglia, F
    Steinmetz, M
    Nagy, ZA
    NATURE BIOTECHNOLOGY, 1999, 17 (06) : 562 - 567
  • [44] Phagocytic processing of antigens for presentation by class II major histocompatibility complex molecules
    Ramachandra, L
    Noss, E
    Boom, WH
    Harding, CV
    CELLULAR MICROBIOLOGY, 1999, 1 (03) : 205 - 214
  • [45] Presentation of cytosolic glycosylated peptides by human class I major histocompatibility complex molecules in vivo
    Haurum, JS
    Hoier, IB
    Arsequell, G
    Neisig, A
    Valencia, G
    Zeuthen, J
    Neefjes, J
    Elliott, T
    JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 190 (01): : 145 - 150
  • [46] The requirement for proteasome activity in class I major histocompatibility complex antigen presentation is dictated by the length of preprocessed antigen
    Yang, B
    Hahn, YS
    Hahn, CS
    Braciale, TJ
    JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 183 (04): : 1545 - 1552
  • [47] Mechanisms of major histocompatibility complex class II-restricted processing and presentation of the V antigen of Yersinia pestis
    Shim, Ho-Ki
    Musson, Julie A.
    Harper, Helen M.
    McNeill, Hesta V.
    Walker, Nicola
    Flick-Smith, Helen
    von Delwig, Alexei
    Williamson, E. Diane
    Robinson, John H.
    IMMUNOLOGY, 2006, 119 (03) : 385 - 392
  • [48] Pleiotropic consequences of metabolic stress for the major histocompatibility complex class II molecule antigen processing and presentation machinery
    Clement, Cristina C.
    Nanaware, Padma P.
    Yamazaki, Takahiro
    Negroni, Maria Pia
    Ramesh, Karthik
    Morozova, Kateryna
    Thangaswamy, Sangeetha
    Graves, Austin
    Kim, Hei Jung
    Li, Tsai Wanxia
    Vigano', Marco
    Soni, Rajesh K.
    Gadina, Massimo
    Tse, Harley Y.
    Galluzzi, Lorenzo
    Roche, Paul A.
    Denzin, Lisa K.
    Stern, Lawrence J.
    Santambrogio, Laura
    IMMUNITY, 2021, 54 (04) : 721 - +
  • [49] Post-proteasomal antigen processing for major histocompatibility complex class I presentation
    Rock, KL
    York, IA
    Goldberg, AL
    NATURE IMMUNOLOGY, 2004, 5 (07) : 670 - 677
  • [50] Peptide generation in the major histocompatibility complex class I antigen processing and presentation pathway
    Androlewicz, MJ
    CURRENT OPINION IN HEMATOLOGY, 2001, 8 (01) : 12 - 16